UnicoCell collaborated with Chang Gung Memorial Hospital(Linkou Branch) to receive approval for the cell preparation site from the MOHW. Cause of occurrence: According to ?The Regulations Governing the Application of Specific Medical Examination Technique and Medical Device?(RASMET) by the Ministry of Health and Welfare (MOHW), company's Cell Processing Unit operates as a cell preparation site for Chang Gung Memorial Hospital (Linkou Branch). The application pertains to the cell therapy technology plan which use autologous adipose-derived stem cell to treat Knee Osteoarthritis.

Unicocell?s Cell Processing Unit was approved by the MOHW on June 5, 2024, in compliance with Good Tissue Practice (GTP) operations. The approved items for the project prior to Chang Gung Memorial Hospital (Linkou Branch) application are as follows: Cellular therapy technology: Autologous adipose-derived stem cell, Indications:Knee Osteoarthritis, and Cell preparation site: Unicocell?s Cell Processing Unit. Approved validity period: From June 4, 2024 to November 8, 2026.